Pneumopathie immuno-induite : un diagnostic différentiel de la pneumopathie à SARS-CoV-2

INTRODUCTION: Immune checkpoint inhibitors have revolutionized the management of many cancers and achieved efficacy and durable response for some patients, including those with advanced cancers. However, immunotherapy is associated with side effects caused by the infiltration of immune cells into no...

Descripción completa

Detalles Bibliográficos
Autores principales: Nigen, B., Chéné, A.-L., Liberge, R., Sagan, C., Blanc, F.-X.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SPLF. Published by Elsevier Masson SAS. 2022
Materias:
Cas Clinique
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9283672/
https://www.ncbi.nlm.nih.gov/pubmed/35906150
http://dx.doi.org/10.1016/j.rmr.2022.07.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9283672/
https://www.ncbi.nlm.nih.gov/pubmed/35906150
http://dx.doi.org/10.1016/j.rmr.2022.07.001

Ejemplares similares